Journals

The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations
Vaccines
The Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and OperationsThe Next Frontier for Viral-Vector Vaccines: Considerations for Manufacturing and Operations
byBrian Gazaille, Stefano Colloca
Feb 9, 2023
SARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production Globally
Vaccines
SARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production GloballySARS-CoV-2 Variants: A Case for Expanding mRNA Vaccine Production Globally
byMahesh Bhalgat
Feb 9, 2023

All Journals

Leishmaniasis — a Forgotten Epidemic
Vaccines
Leishmaniasis — a Forgotten Epidemic
Leishmaniasis — a Forgotten Epidemic
Feb 9, 2023
+4
byFlavia D'Alessio, Sophie Houardand 4 more
Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment
Vaccines
Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment
Water-Proton Nuclear Magnetic Resonance Spectroscopy: Emerging Applications for Vaccine Quality Assessment
Feb 9, 2023
byBrian Gazaille, Marc B. Taraban
Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography
Sponsored Content
Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography
Production and Purification of Newcastle Disease Virus: A High-Yield Platform Process Based on a Novel Avian Cell Line and Monolith Chromatography
Feb 9, 2023
+8
byHana Jug, Natalija Hostaand 8 more
January-February 2023: From the Editor
Business
January-February 2023: From the Editor
January-February 2023: From the Editor
Feb 9, 2023
byS Anne Montgomery
The Talent Enigma in Digital Biomanufacturing
Careers & Training
The Talent Enigma in Digital Biomanufacturing
The Talent Enigma in Digital Biomanufacturing
Feb 9, 2023
+5
byJason Beckwith, Paul Rooneyand 5 more
Delivering the Digital Skills Needs of the Bioprocessing Sector: Realizing the Vision of Industry 4.0 for Your Organization
Careers & Training
Delivering the Digital Skills Needs of the Bioprocessing Sector: Realizing the Vision of Industry 4.0 for Your Organization
Delivering the Digital Skills Needs of the Bioprocessing Sector: Realizing the Vision of Industry 4.0 for Your Organization
Feb 9, 2023
+2
bySuzanne S. Farid, Duygu Dikiciogluand 2 more
Overcoming AAV Manufacturing Challenges: Movement Toward Plug-and-Play Solutions
Cell Therapies
Overcoming AAV Manufacturing Challenges: Movement Toward Plug-and-Play Solutions
Overcoming AAV Manufacturing Challenges: Movement Toward Plug-and-Play Solutions
Feb 9, 2023
byMaggie Chen
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
QA/QC
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
Opportunities in the Field of Host Cell Proteins — Part 4: The Future of Immunogenicity Prediction
Feb 9, 2023
+1
byVíctor Pérez Medina Martínez, Carlos Eduardo Espinosa-de la Garzaand 1 more
Shear-Proof Design Space: Scaling Stirred-Tank Bioreactors for Cell Culture Processes
Bioreactors
Shear-Proof Design Space: Scaling Stirred-Tank Bioreactors for Cell Culture Processes
Shear-Proof Design Space: Scaling Stirred-Tank Bioreactors for Cell Culture Processes
Feb 9, 2023
byNaveenganesh Muralidharan
Real-Time, Data-Driven, and Predictive Modeling: Accelerating Digital Transformation in Drug Substance Commercial Manufacturing
PAT
Real-Time, Data-Driven, and Predictive Modeling: Accelerating Digital Transformation in Drug Substance Commercial Manufacturing
Real-Time, Data-Driven, and Predictive Modeling: Accelerating Digital Transformation in Drug Substance Commercial Manufacturing
Feb 9, 2023
+1
byPablo J. Rosado, Badua Merheband 1 more
Save Valuable Facility Time with Single-Use TFF
Sponsored Content
Save Valuable Facility Time with Single-Use TFF
Save Valuable Facility Time with Single-Use TFF
Feb 9, 2023
+2
byFranziska Froboese, Katy McLaughlinand 2 more
Less Is More in mRNA Therapeutics: Developing Big Ideas at Small Scales
Sponsored Content
Less Is More in mRNA Therapeutics: Developing Big Ideas at Small Scales
Less Is More in mRNA Therapeutics: Developing Big Ideas at Small Scales
Feb 9, 2023
byLinda Mathiasson
Grow Your CDMO with Automated Aseptic-Filling Workcells
Sponsored Content
Grow Your CDMO with Automated Aseptic-Filling Workcells
Grow Your CDMO with Automated Aseptic-Filling Workcells
Feb 9, 2023
byJohn Harmer
Shaken or Stirred: Comparing Rocking-Motion and Impeller Technology in Cell Cultivation
Sponsored Content
Shaken or Stirred: Comparing Rocking-Motion and Impeller Technology in Cell Cultivation
Shaken or Stirred: Comparing Rocking-Motion and Impeller Technology in Cell Cultivation
Feb 9, 2023
byTobias Schenk
Cell-Expansion Benefits Using Hollow-Fiber Bioreactor Technology
Sponsored Content
Cell-Expansion Benefits Using Hollow-Fiber Bioreactor Technology
Cell-Expansion Benefits Using Hollow-Fiber Bioreactor Technology
Feb 9, 2023
byStuart Gibb
How To Achieve DSCSA Compliance by November 2023
Supply Chain
How To Achieve DSCSA Compliance by November 2023
How To Achieve DSCSA Compliance by November 2023
Feb 9, 2023
byAndre Caprio
eBook: Cell Therapy — Lessons Learned from Working with Vectors and Cells
Cell Therapies
eBook: Cell Therapy — Lessons Learned from Working with Vectors and Cells
eBook: Cell Therapy — Lessons Learned from Working with Vectors and Cells
Jan 31, 2023
+5
byBrian Gazaille, Joseph B. Lillegardand 5 more
The Best Places to Work in Biotech: Perspectives on Job Satisfaction in the Biopharmaceutical Ecosystem
Careers & Training
The Best Places to Work in Biotech: Perspectives on Job Satisfaction in the Biopharmaceutical Ecosystem
The Best Places to Work in Biotech: Perspectives on Job Satisfaction in the Biopharmaceutical Ecosystem
Dec 20, 2022
byS. Anne Montgomery
eBook: mRNA — Negotiating New Manufacturing Hurdles
Vaccines
eBook: mRNA — Negotiating New Manufacturing Hurdles
eBook: mRNA — Negotiating New Manufacturing Hurdles
Dec 20, 2022
+2
byJake Adams, Dan Stantonand 2 more
Cell Therapy — Supply Chain Discussions
Supply Chain
Cell Therapy — Supply Chain Discussions
Cell Therapy — Supply Chain Discussions
Dec 15, 2022
+3
byDan Stanton, Gareth Macdonaldand 3 more
Improving Scalability of AAV and Lentivirus Production: Tailored Transfection Reagents Enable Large-Scale Manufacturing
Sponsored Content
Improving Scalability of AAV and Lentivirus Production: Tailored Transfection Reagents Enable Large-Scale Manufacturing
Improving Scalability of AAV and Lentivirus Production: Tailored Transfection Reagents Enable Large-Scale Manufacturing
Dec 15, 2022
byMiguel Dominguez
Introduction: Viral Clearance and Inactivation in Downstream Processing
Viral Clearance
Introduction: Viral Clearance and Inactivation in Downstream Processing
Introduction: Viral Clearance and Inactivation in Downstream Processing
Dec 12, 2022
byCheryl Scott
Triton X-100 Elimination: The Road Ahead for Viral Inactivation
Viral Clearance
Triton X-100 Elimination: The Road Ahead for Viral Inactivation
Triton X-100 Elimination: The Road Ahead for Viral Inactivation
Dec 12, 2022
byKurt Brorson, Christiane Niederlaender
Worst-Case Conditions for Viral Clearance
Viral Clearance
Worst-Case Conditions for Viral Clearance
Worst-Case Conditions for Viral Clearance
Dec 12, 2022
+7
byDhiral A. Shah, James Berrieand 7 more
Hollow-Fiber Nanofiltration for Robust Viral Clearance of Non-MAb Biologics
Filtration
Hollow-Fiber Nanofiltration for Robust Viral Clearance of Non-MAb Biologics
Hollow-Fiber Nanofiltration for Robust Viral Clearance of Non-MAb Biologics
Dec 12, 2022
+5
byJi Zheng, Jessica A. Wallerand 5 more
November-December 2022: From the Editors
Business
November-December 2022: From the Editors
November-December 2022: From the Editors
Dec 12, 2022
byS Anne Montgomery, Maribel Rios
Increasing Clinical Trial Inclusivity: Technology-Enabled Community Connections
Pre-Clinical & Clinical Trials
Increasing Clinical Trial Inclusivity: Technology-Enabled Community Connections
Increasing Clinical Trial Inclusivity: Technology-Enabled Community Connections
Dec 12, 2022
byLiz Beatty
The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision
Risk Management
The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision
The State of Quality Risk Management in the Pharmaceutical Industry: Commentary on the Draft ICH Q9 Revision
Dec 12, 2022
byKate Coleman
Using Synthetic Biology To Develop Novel Biotherapeutics
Emerging Therapeutics
Using Synthetic Biology To Develop Novel Biotherapeutics
Using Synthetic Biology To Develop Novel Biotherapeutics
Dec 12, 2022
byDavid L. Hava
Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy
Single Use
Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy
Container Materials for Biopharmaceuticals: A Comparative Small-Scale Case Study of Stainless Steel and a Proprietary Nickel-Based Alloy
Dec 12, 2022
+5
bySonia Bedi, Mintai Peter Hwangand 5 more
Ensuring Single-use Systems Integrity in Aseptic or Closed-Process Applications
Sponsored Content
Ensuring Single-use Systems Integrity in Aseptic or Closed-Process Applications
Ensuring Single-use Systems Integrity in Aseptic or Closed-Process Applications
Dec 8, 2022
+1
byMarc Hogreve, Inga Reinertand 1 more
Purity by Design
Sponsored Content
Purity by Design
Purity by Design
Dec 8, 2022
+4
byTerry Pizzie, Sujeong Yangand 4 more
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
Separation/Purification
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
Opportunities in the Field of Host Cell Proteins Part 3: Case Studies in Impurity Detection and Identification
Dec 6, 2022
+1
byVíctor Pérez Medina Martínez, Carlos Eduardo Espinosa-de la Garzaand 1 more

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management CollaborationRegister Now: From Concept to Cleanroom - Case Studies in Single-Use Fluid Management Collaboration
Ask the Expert webcasts
ATE Webcasts
Register Now: Process Intensification Through Perfused N-1 BioreactorRegister Now: Process Intensification Through Perfused N-1 Bioreactor
Ask the Expert webcasts
ATE Webcasts
Register Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV ProductionRegister Now: Building Reliability Into Scale-Up: Targeted Optimization for AAV Production
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

Thermo Fisher Plan for Success WP
Sponsored Content
Increase Efficiency and Reduce Costs in Bioprocessing: A Strategic GuideIncrease Efficiency and Reduce Costs in Bioprocessing: A Strategic Guide
byBPI Contributor
Aug 14, 2024
1 Min Read
Valgenesis transforming pharmaceutical development
Sponsored Content
Transforming Pharmaceutical Development: Combining Digital Platforms and QbD PrinciplesTransforming Pharmaceutical Development: Combining Digital Platforms and QbD Principles
byBPI Contributor
Aug 7, 2024
1 Min Read
Thermo Maximizing Scale Up
Sponsored Content
Navigating the Complexities of Buffer Preparation in Biopharmaceutical ManufacturingNavigating the Complexities of Buffer Preparation in Biopharmaceutical Manufacturing
byBPI Contributor
Aug 5, 2024
1 Min Read